NY-ESO-1 Peptide vaccine
STUDY00005324
Phase 2 mab active
Quick answer
NY-ESO-1 Peptide vaccine for Ovarian Cancer Stage IV is a Phase 2 program (mab) at Coherus Oncology with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Coherus Oncology
- Indication
- Ovarian Cancer Stage IV
- Phase
- Phase 2
- Modality
- mab
- Status
- active